Arshia Bhardwaj

Arshia Bhardwaj

Auto-generated profile, based on publicly available information

Arshia Bhardwaj

Department of Gastroenterology, Dayanand Medical College and Hospital, Ludhiana, India

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2025 in eClinicalMedicine
Verified
Journal Article
Open access
ASArshdeep Singh
Arshdeep Singh
ABArshia Bhardwaj
Arshia Bhardwaj
RSRiya Sharma
Riya Sharma
VMVandana Midha
Vandana Midha
ASAjit Sood
Ajit Sood
The global burden of inflammatory bowel disease (IBD) is progressively increasing, with a particularly sharp rise in newly industrialized and resource-limited settings. These regions face unique and pressing challenges in IBD care, including a shortage of trained specialists, delayed or missed diagnoses, financial and geographic barriers to access, and the persistent stigma surrounding the disease. Furthermore, cultural dynamics; especially the prominent role of family in healthcare decisions; profoundly influence patient engagement, treatment adherence, and overall outcomes. However, current healthcare models and global guidelines are largely shaped by Western systems that prioritize individual patient autonomy and may not fully align with the sociocultural realities of resource-limited settings. This viewpoint aims to highlight the need for culturally contextualized, scalable solutions to improve IBD care. Specifically, we propose the development and integration of IBD counsellors as a novel and pragmatic approach to bridge existing gaps in care. These counsellors, trained in the nuances of IBD and sensitive to local sociocultural norms, can serve as critical intermediaries; facilitating communication among patients, families, and providers; supporting adherence and follow-up; and offering tailored psychosocial and dietary guidance. By presenting this model, we seek to stimulate discourse around innovative, culturally adaptive strategies and advocate for policy-level recognition and investment to promote health equity in IBD care globally.

30 April 2025 in Intestinal Research
Verified
Journal Article
Open access
PDF file
ASArshdeep Singh
Arshdeep Singh
ABArshia Bhardwaj
Arshia Bhardwaj
RSRiya Sharma
Riya Sharma
BKBhavjeet Kaur Kahlon
Bhavjeet Kaur Kahlon
ADAshvin Singh Dhaliwal
Ashvin Singh Dhaliwal
ASAjit Sood
Ajit Sood
Background/Aims: Accurate assessment of disease activity is crucial for effective management and treatment of ulcerative colitis (UC). This study evaluated the correlation between clinical, endoscopic, and histologic measures of disease activity in UC. Methods: Clinical, biochemical, endoscopic, and histologic disease activity was studied in 347 patients with UC. Agreements among various histologic classification systems, namely the Geboes Score (GS), Continuous GS, Nancy Index (NI), and Robarts Histopathology Index (RHI), were analyzed. The predictive accuracy of fecal calprotectin (FC) for endoscopic and histologic remission was assessed. Results: We demonstrate a fair to moderate correlation between clinical, endoscopic, and histologic measures of disease activity in UC. There was a robust concordance among GS, Continuous GS, NI, and RHI in distinguishing between patients in histologic remission or activity. The NI detected 75% of patients who met the remission criteria according to the RHI, whereas the RHI identified all patients in remission as defined by the NI. FC levels below 150 μg/g had >70% accuracy in predicting endoscopic remission. FC levels below 150 μg/g showed ≥80% accuracy, and FC levels below 100 μg/g demonstrated ≥ 85% accuracy in predicting histologic remission, regardless of the scoring index applied. Elevated FC levels were associated with both acute and chronic inflammatory infiltrates in biopsy samples. Conclusions: FC is a reliable predictor of histologic remission, with higher accuracy at lower thresholds. The GS, Continuous GS, NI, and RHI demonstrate comparable performance. FC could help stratify patients’ need for colonoscopy for the assessment of endoscopic and histologic remission.

30 April 2026 in Intestinal Research
Verified
Journal Article
Open access
PDF file
ASArshdeep Singh
Arshdeep Singh
MLMayur Luthra
Mayur Luthra
ABArshia Bhardwaj
Arshia Bhardwaj
RMRamit Mahajan
Ramit Mahajan
RSRiya Sharma
Riya Sharma
ASAjit Sood
Ajit Sood
Background/Aims: Acute severe ulcerative colitis (ASUC) is a time-critical situation requiring urgent intervention. Limited data exist on the evolving clinical spectrum of ASUC in the era of advanced therapies. Methods: This prospective real-world observational cohort study included 145 adult patients hospitalized with ASUC between January 2020 and June 2024. ASUC was defined by the modified Truelove and Witts criteria. Demographics and disease characteristics, including disease severity, probable precipitating factors, and corticosteroid failure rates, were recorded. Results: The median age of patients was 36 years (interquartile range, 26–48.5 years) with 63 females (43.4%). Most patients had left-sided colitis (53.1%). The median disease duration was 1 year (IQR, 0.5–3 years), with 91 patients (62.7%) presenting with ASUC within the first year of diagnosis of ulcerative colitis. One-third of the patients had previous exposure to biologics and small molecules. The most commonly reported probable precipitants of ASUC were poor compliance with treatment (n = 43, 29.6%), antibiotic use (n = 35, 24.1%), high perceived stress (n = 32, 22.1%), and Clostridioides difficile infection (n = 19, 13.1%). Forty patients (27.5%) were non-responders to intravenous corticosteroids (IVCS). Twenty-nine patients (20%) received medical rescue therapy (infliximab, n = 14 [48.27%], cyclosporine A, n = 6 [20.68%], and tofacitinib, n = 9 [31.03%]). Seven patients (4.82%; 4 after non-response to IVCS and 3 after non-response to medical rescue therapy) underwent colectomy. Conclusions: In this cohort of ASUC patients, poor treatment compliance, antibiotic use, stress, and C. difficile infection were common precipitants of flare-ups. Nearly one-third of patients required medical rescue therapy, and a small proportion ultimately underwent colectomy.

14 November 2025 in Intestinal Research
Verified
Journal Article
Open access
PDF file
ABArshia Bhardwaj
Arshia Bhardwaj
ASArshdeep Singh
Arshdeep Singh
RSRiya Sharma
Riya Sharma
VMVandana Midha
Vandana Midha
ASAjit Sood
Ajit Sood
A survey on the practices and patterns in the management of acute severe ulcerative colitis in India

19 August 2026 in Indian Journal of Gastroenterology
Verified
Journal Article
Closed access
PDF file
AKAshanpreet Kaur
Ashanpreet Kaur
ASArshdeep Singh
Arshdeep Singh
ABArshia Bhardwaj
Arshia Bhardwaj
SSSaurabh Singla
Saurabh Singla
SSSuryaveer Singh
Suryaveer Singh
ASAjit Sood
Ajit Sood

19 July 2025 in Indian Journal of Gastroenterology
Verified
Journal Article
Closed access
ASArshdeep Singh
Arshdeep Singh
CKChandan Kakkar
Chandan Kakkar
Pietro Andrea BonaffiniPietro Andrea Bonaffini
Pietro Andrea Bonaffini
ABArshia Bhardwaj
Arshia Bhardwaj
ASAshi Sachdeva
Ashi Sachdeva
ASAjit Sood
Ajit Sood